CLINICAL_TRIALS
trial_result
· 2019-03-05
Clinical Trial Update: Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder [Phase 2]
Summary
Phase 2 clinical trial evaluating cariprazine as adjunctive therapy for major depressive disorder has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2019-03-05